Ocean Sciences Ltd (ASX:OSS)

Australia · Delayed Price · Currency is AUD

0.0100

-0.0020 (-16.67%)

Last updated: Nov 6, 2026, 12:38 PM AEDT

Market Cap	2.35M -9.5%
Revenue (ttm)	3.44M +1,359.6%
Net Income	-1.74M
EPS	-0.01
Shares Out	235.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,338
Open	0.0110
Previous Close	0.0120
Day's Range	0.0100 - 0.0110
52-Week Range	0.0100 - 0.0300
Beta	0.37
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About Ocean Sciences

Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. Ocean Sciences Ltd was formerly known as BPH Global Ltd and changed its name to Ocean Sciences Ltd in September 202... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1984

Employees 31

Stock Exchange Australian Securities Exchange

Ticker Symbol OSS

Full Company Profile

Financial Performance

In fiscal year 2026, Ocean Sciences's revenue was 3.44 million, an increase of 1359.59% compared to the previous year's 235,990. Losses were -1.74 million, 16.9% more than in 2025.

Financial Statements